POLYVIEW IHC試劑：高靈敏度、低背景納米聚合物檢測(cè)試劑，適用于 HIGHDEF 顯色劑。

POLYVIEW®（小鼠/兔-HRP）IHC檢測(cè)試劑是一種非生物素一步法檢測(cè)試劑，適用于檢測(cè)福爾馬林固定石蠟包埋組織和冷凍切片中的抗原。HRP 檢測(cè)試劑也可用于血涂片、細(xì)胞涂片和細(xì)胞制劑。

艾美捷POLYVIEW IHC試劑 #ADI-950-113-0100特點(diǎn)：

無生物素納米聚合物檢測(cè)規(guī)避內(nèi)源性生物素背景

高強(qiáng)度顯色帶來銳利、清晰的染色效果

使用您選擇的 HIGHDEF® 顯色劑進(jìn)行定制（單獨(dú)出售）

POLYVIEW IHC試劑規(guī)格：

應(yīng)用： 免疫接種

內(nèi)容： 抗小鼠/兔HRP檢測(cè)試劑

航運(yùn)： 藍(lán)冰不結(jié)冰

長(zhǎng)期儲(chǔ)存：+4°C

技術(shù)信息：POLYVIEW® IHC 檢測(cè)試劑 （小鼠/兔-HRP） 是通過使用專有的串聯(lián)超標(biāo)記技術(shù)用酶直接標(biāo)記抗小鼠和抗兔免疫球蛋白而開發(fā)的。這可確保使用單一試劑對(duì)小鼠和兔抗體進(jìn)行一致且可重現(xiàn)的免疫檢測(cè)。可以輕松檢測(cè)不同類型組織中的核、細(xì)胞質(zhì)和膜抗原。POLYVIEW® IHC 檢測(cè)試劑（小鼠/兔-HRP）比使用生物素和親和素/鏈霉親和素偶聯(lián)物的傳統(tǒng)兩步法可實(shí)現(xiàn)更快的染色程序，且背景顯著降低。該試劑盒適用于所有小鼠和兔抗體，包括單克隆和多克隆抗體。該試劑可用于手動(dòng)染色或與自動(dòng)染色平臺(tái)配合使用。

RUO - 僅供研究使用

POLYVIEW IHC試劑部分文獻(xiàn)參考：

The differing pathophysiologies that underlie COVID 19-associated perniosis and thrombotic retiform purpura: a case series: C.M. Magro, et al.; Br. J. Dermatol. 184, 141 (2021), Application(s): IHC on automated platform. Dermal samples.,

Analysis of complement deposition and viral RNA in placentas of COVID 19 patients: J.J. Mulvey, et al.; Ann. Diagn. Pathol. 46, 151530 (2020), Application(s): IHC on automated platform; human placenta (SARS-CoV-2 spike protein detection),

Importin-β and exportin-5 are indicators of acute viral infection: Correlation of their detection with commercially available detection kits: G.J. Nuovo, et al.; Ann. Diagn. Pathol. 34, 36 (2018), Application(s): Comparison with Leica HRP. IHC on: infected brain tissues with rabies virus; mice infected with acute reovirus infection; CIN, Herpes simplex virus and molloscum contagiosum lesions;

Increased expression of importin-β, exportin-5 and nuclear transportable proteins in Alzheimer's disease aids anatomic pathologists in its diagnosis: G. Nuovo, et al.; Ann. Diag. Pathol. 32, 10 (2018), Application(s): Immunohistochemistry on human brain FFPE tissue;

New biomarkers of human papillomavirus infection in acute cervical intraepithelial neoplasia: G.J. Nuovo, et al.; Ann. Diagn. Pathol. 36, 21 (2018);